v3.26.1
Description of Business, Organization and Liquidity - Additional Information (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 6 Months Ended
Jul. 16, 2026
Feb. 10, 2026
Feb. 09, 2026
Nov. 10, 2025
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Feb. 08, 2026
Dec. 31, 2025
Description Of Business Organization And Liquidity [Line Items]                    
Cash and cash equivalents         $ 540,515   $ 540,515     $ 257,624
Accumulated deficit         546,320   546,320     487,363
Net loss         (31,200) $ (3,400) (58,957) $ (5,970)    
Cash flows from operating activities             (42,465) $ (4,676)    
Cash, cash equivalents and marketable securities                   257,600
Current assets         543,588   543,588     260,423
Current liabilities         $ 27,550   $ 27,550     $ 20,066
Common stock, authorized     500,000,000   500,000,000   500,000,000   300,000,000 300,000,000
Common stock, issued         61,734,601   61,734,601     1,597,321
Common stock, par value         $ 0.00001   $ 0.00001     $ 0.00001
Common Stock                    
Description Of Business Organization And Liquidity [Line Items]                    
Issuance of Series C preferred stock in PIPE, net of issuance costs (in shares)             16,644,737      
Underwriting Agreement                    
Description Of Business Organization And Liquidity [Line Items]                    
Sale of stock, number of shares issued in transaction   16,644,737                
Sale of stock, price per share   $ 19                
Net proceeds from the underwritten offering   $ 295,500                
Offering costs   $ 20,800                
Over-Allotment Option | Underwriting Agreement                    
Description Of Business Organization And Liquidity [Line Items]                    
Sale of stock, number of shares issued in transaction   2,171,052                
Series B Non-Voting Convertible Preferred Stock                    
Description Of Business Organization And Liquidity [Line Items]                    
Preferred stock, issued         16,366   16,366     16,366
Preferred stock, par value         $ 0.00001   $ 0.00001     $ 0.00001
Number of preferred stock converted into common stock       1,000            
Series C Non-Voting Convertible Preferred Stock                    
Description Of Business Organization And Liquidity [Line Items]                    
Preferred stock, issued       43,882 1,722   1,722     43,882
Preferred stock, par value         $ 0.00001   $ 0.00001     $ 0.00001
Number of preferred stock converted into common stock     42,005 1,000            
Series C Preferred Stock                    
Description Of Business Organization And Liquidity [Line Items]                    
Number of preferred stock converted into common stock     42,005              
Series C Preferred Stock | Common Stock                    
Description Of Business Organization And Liquidity [Line Items]                    
Number of preferred stock converted into common stock     42,005,000              
Damora Therapeutics, Inc.                    
Description Of Business Organization And Liquidity [Line Items]                    
Asset acquisition, date of acquisition agreement       Nov. 10, 2025            
Common stock, issued       265,309            
Common stock, par value       $ 0.00001            
Damora Therapeutics, Inc. | Underwriting Agreement                    
Description Of Business Organization And Liquidity [Line Items]                    
Sale of stock, number of shares issued in transaction   16,644,737                
Sale of stock, price per share   $ 19                
Net proceeds from the underwritten offering   $ 295,500                
Offering costs   $ 20,800                
Damora Therapeutics, Inc. | Over-Allotment Option | Underwriting Agreement                    
Description Of Business Organization And Liquidity [Line Items]                    
Sale of stock, number of shares issued in transaction   2,171,052                
Damora Therapeutics, Inc. | Series B Non-Voting Convertible Preferred Stock                    
Description Of Business Organization And Liquidity [Line Items]                    
Preferred stock, issued       16,366            
Preferred stock, par value       $ 0.00001            
Damora Therapeutics, Inc. | Series C Non-Voting Convertible Preferred Stock                    
Description Of Business Organization And Liquidity [Line Items]                    
Preferred stock, issued       4,241            
Preferred stock, par value       $ 0.00001            
Damora Therapeutics, Inc. | Series C Non-Voting Convertible Preferred Stock | Private Placement                    
Description Of Business Organization And Liquidity [Line Items]                    
Number of preferred stock converted into common stock       1,000            
Issuance of Series C preferred stock in PIPE, net of issuance costs (in shares)       39,641            
Gross proceeds from issuance of preferred stock in connection with private placement, net of issuance costs       $ 285,000            
Damora Therapeutics, Inc. | Series B and Series C Convertible Preferred Stock                    
Description Of Business Organization And Liquidity [Line Items]                    
Number of preferred stock converted into common stock       1,000            
Damora Delaware                    
Description Of Business Organization And Liquidity [Line Items]                    
Common stock, par value $ 0.00001                  
Damora Delaware | Common Stock                    
Description Of Business Organization And Liquidity [Line Items]                    
Number of preferred stock converted into common stock 1                  
Damora Delaware | Series B Preferred Stock                    
Description Of Business Organization And Liquidity [Line Items]                    
Preferred stock, par value $ 0.00001                  
Damora Delaware | Series C Preferred Stock                    
Description Of Business Organization And Liquidity [Line Items]                    
Preferred stock, par value $ 0.00001                  
Number of preferred stock converted into common stock 1                  
Damora Delaware | Convertible Common Stock                    
Description Of Business Organization And Liquidity [Line Items]                    
Common stock, par value $ 0.00001